Tumor antigens can be captured and processed by dendritic cells, which can be stimulated by Lipo-MP-LPS, as described for other TLR4 agonists [66], leading to the secondary activation of CD4 and CD8 T-cells in periphery. Here, CD8A is linked to neoplasm.